Skip to main content
Top

Drugs

Issue 8/2014

Content (9 Articles)

Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update

  • Current Opinion

Abdullah Alsultan, Charles A. Peloquin

Next-Generation Phosphate Binders: Focus on Iron-Based Binders

  • Leading Article

Dimitra Nastou, Beatriz Fernández-Fernández, Usama Elewa, Liliana González-Espinoza, Emilio González-Parra, Maria D. Sanchez-Niño, Alberto Ortiz

First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions

  • Review Article

Antonio González-Martín, Luisa Sánchez-Lorenzo, Raquel Bratos, Raúl Márquez, Luis Chiva

Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications

  • Review Article

Julie Autmizguine, Jeffrey T. Guptill, Michael Cohen-Wolkowiez, Daniel K. Benjamin Jr, Edmund V. Capparelli

The Evolution of Insulin Glargine and its Continuing Contribution to Diabetes Care

  • Open Access
  • Review Article

Rolf Hilgenfeld, Gerhard Seipke, Harald Berchtold, David R. Owens

Albiglutide: First Global Approval

  • R&D Insight Report

Raewyn M. Poole, Mary L. Nowlan

Tofogliflozin: First Global Approval

  • R&D Insight Report

Raewyn M. Poole, Jennifer E. Prossler

Luseogliflozin: First Global Approval

  • R&D Insight Report

Anthony Markham, Shelley Elkinson

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images